Physician profile
Walter E Stotz
NPI 1467437483
$555.52
in general payments reported to CMS, 2019-2025
16 companies · $93.72 in 2025
The $93.72 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.11 · 2020: $111 · 2021: $42.14 · 2022: $132 · 2024: $105 · 2025: $93.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $112.15 | 2020-2022 | |
| Pfizer INC. | $83.78 | 2019-2024 | |
| Abbvie INC. | $64.54 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $46.68 | 2020-2025 | Airsupra |
| Amarin Pharma, INC. | $41.36 | 2020-2022 | |
| Inspire Medical Systems, INC. | $28.36 | 2025 | Inspire |
| Novo Nordisk INC | $24.22 | 2019 | |
| Sumitomo Pharma America, INC. | $23.68 | 2024 | Gemtesa |
| Medtronic, INC. | $23.02 | 2024 | Venaseal |
| Novartis Pharmaceuticals Corporation | $17.39 | 2020 | |
| Horizon Therapeutics Plc | $17.39 | 2019 | |
| Exact Sciences Corporation | $15.72 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $15.34 | 2022 | |
| Grifols USA, LLC | $15.09 | 2020 | |
| Seqirus USA INC | $15.06 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Stotz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.